Thought Leadership
Thought-provoking insights from an executive search perspective on the latest biopharma news, market shifts, and industry milestones.
The Integral Role of CDMOs for the Future of the U.S. Biopharma Industry
Disruptive biotech companies developing cell and gene therapies (CGT) and other precision medicines remain imperative for industry evolution, and specifically, Contract Development Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) will play a critical role in the coming years.
Setting Sights on Korea as a new Biotech Hub
Demographically, South Korea has been an appealing investment opportunity for pharma companies. It has a relatively large population of around 51 million people…